Instil Bio Statistics
Share Statistics
Instil Bio has 6.53M shares outstanding. The number of shares has increased by 0.34% in one year.
| Shares Outstanding | 6.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.34% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.05M |
| Failed to Deliver (FTD) Shares | 287 |
| FTD / Avg. Volume | 0.23% |
Short Selling Information
The latest short interest is 376.00K, so 5.76% of the outstanding shares have been sold short.
| Short Interest | 376.00K |
| Short % of Shares Out | 5.76% |
| Short % of Float | 12.32% |
| Short Ratio (days to cover) | 2.29 |
Valuation Ratios
The PE ratio is -0.32 and the forward PE ratio is -3.
| PE Ratio | -0.32 |
| Forward PE | -3 |
| PS Ratio | 0 |
| Forward PS | 33 |
| PB Ratio | 0.22 |
| P/FCF Ratio | -0.48 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Instil Bio Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.22, with a Debt / Equity ratio of 0.36.
| Current Ratio | 15.22 |
| Quick Ratio | 15.22 |
| Debt / Equity | 0.36 |
| Total Debt / Capitalization | 26.5 |
| Cash Flow / Debt | -1.01 |
| Interest Coverage | -17.38 |
Financial Efficiency
Return on equity (ROE) is -0.69% and return on capital (ROIC) is -29.03%.
| Return on Equity (ROE) | -0.69% |
| Return on Assets (ROA) | -0.48% |
| Return on Capital (ROIC) | -29.03% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.19M |
| Employee Count | 49 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 170.3% in the last 52 weeks. The beta is 1.74, so Instil Bio 's price volatility has been higher than the market average.
| Beta | 1.74 |
| 52-Week Price Change | 170.3% |
| 50-Day Moving Average | 24.73 |
| 200-Day Moving Average | 21.58 |
| Relative Strength Index (RSI) | 43.38 |
| Average Volume (20 Days) | 125.43K |
Income Statement
| Revenue | n/a |
| Gross Profit | -4.76M |
| Operating Income | -90.54M |
| Net Income | -156.09M |
| EBITDA | -146.12M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -24 |
Balance Sheet
The company has 9.20M in cash and 86.05M in debt, giving a net cash position of -76.86M.
| Cash & Cash Equivalents | 9.20M |
| Total Debt | 86.05M |
| Net Cash | -76.86M |
| Retained Earnings | -580.98M |
| Total Assets | 272.56M |
| Working Capital | 122.29M |
Cash Flow
In the last 12 months, operating cash flow was -82.03M and capital expenditures -20.66M, giving a free cash flow of -102.69M.
| Operating Cash Flow | -82.03M |
| Capital Expenditures | -20.66M |
| Free Cash Flow | -102.69M |
| FCF Per Share | -15.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -119.34% |
| FCF Yield | -78.25% |
Analyst Forecast
The average price target for TIL is $110, which is 447% higher than the current price. The consensus rating is "Buy".
| Price Target | $110 |
| Price Target Difference | 447% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Dec 8, 2023. It was a backward split with a ratio of 1:20.
| Last Split Date | Dec 8, 2023 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -2.73 |
| Piotroski F-Score | 2 |